We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Life-threatening Pneumocystis jiroveci Pneumonia with Cytomegalovirus Coinfection in a Follicular Lymphoma Patient During Rituximab-based Chemotherapy.
- Authors
Mu-Chun Yang; Sheng-Kang Chiu; Jong-Kai Hsiao; Woei-Yau Kao
- Abstract
In the era of target therapy, we face the challenge of the risk of opportunistic infection in patients with B-cell lymphoma who receiving rituximab-based chemotherapy. Opportunistic infections such as Pneumocystis jiroveci pneumonia (PJP) and Cytomegalovirus (CMV) pneumonia are life-threatening diseases. However, PJP with CMV coinfection is rare. Here, we report a follicular lymphoma patient who suffered from PJP with CMV coinfection after receiving three cycles of rituximab, cyclophosphamide, vincristine, and prednisone regimen and was successfully rescured after timely identification and treatment. We emphasize that physicians should be alert for the coinfection of PJP and CMV in lymphoma patients receiving rituximab-based chemotherapy and the timely recognition, and treatment that may avoid a deadly outcome.
- Subjects
PNEUMOCYSTIS jiroveci; CANCER chemotherapy; FOLLICULAR lymphoma; RITUXIMAB; CYTOMEGALOVIRUSES
- Publication
Journal of Cancer Research & Practice, 2024, Vol 11, Issue 1, p39
- ISSN
2311-3006
- Publication type
Article
- DOI
10.4103/ejcrp.eJCRP-D-23-00015